Register      Login
Microbiology Australia Microbiology Australia Society
Microbiology Australia, bringing Microbiologists together

Articles citing this paper

Australia’s COVID-19 vaccine journey: progress and future perspectives

James A. Triccas https://orcid.org/0000-0003-3730-2339 A B C * and Megan C. Steain https://orcid.org/0000-0002-7631-4204 A B C
+ Author Affiliations
- Author Affiliations

A Sydney Infectious Diseases Institute (Sydney ID), Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.

B School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.

C Charles Perkins Centre, The University of Sydney, Camperdown, NSW 2006, Australia.




Professor James Triccas is a bacteriologist who uses a multidisciplinary approach to define immunity to chronic bacterial pathogens and develop new treatments to control infection. He is Professor of Medical Microbiology and Deputy Director of the Sydney Institute Infectious Diseases (Sydney ID) at The University of Sydney. He leads the recently established vaccine consortium comprising The University of Sydney, ExcellGene and Bharat Biotech, supported by the Coalition for Epidemic Preparedness Innovations (CEPI), to develop a broadly protective SARS-CoV-2 vaccine.



Dr Megan Steain is a virologist with expertise in host-pathogen interactions and using viruses as vectors to address multiple health challenges. She is a senior lecturer in the Infection, Immunity and Inflammation theme within the School of Medical Sciences at The University of Sydney. She has over 20 years’ experience working with pathogenic human viruses, including HIV, SARS-CoV-2, varicella zoster virus, herpes simplex virus-1 and human cytomegalovirus.

* Correspondence to: jamie.triccas@sydney.edu.au

Microbiology Australia 45(1) 27-31 https://doi.org/10.1071/MA24009
Submitted: 17 January 2024  Accepted: 28 February 2024   Published: 15 March 2024



1 articles found in Crossref database.

Contextualising COVID-19 in 2024
Walker Gregory, Rawlinson William
Microbiology Australia. 2024 45(1). p.3

Committee on Publication Ethics

Abstract Full Text PDF (1.6 MB) Export Citation

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email